Renal Cancer - Results from #3620

Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma. May 2, 2019

The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases. May 1, 2019

An Update on Predictive Biomarkers in Metastatic Renal Cell Carcinoma. May 1, 2019

Circulating obesity-driven biomarkers are associated with risk of clear cell renal cell carcinoma: a two-stage, case-control study. May 1, 2019

Tumor laterality in renal cancer as a predictor of survival in large patient cohorts: A STROBE compliant study. April 30, 2019

A Phase II, single-arm trial of neoadjuvant axitinib plus avelumab in patients with localized renal cell carcinoma who are at high risk of relapse after nephrectomy (NEOAVAX). April 30, 2019

Clinical significance of PD-1 and PD-L1 expression in the tumor microenvironment of clear cell renal cell carcinoma. April 30, 2019

Interferon-induced IFIT5 promotes epithelial-to-mesenchymal transition leading to renal cancer invasion. April 29, 2019

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model. April 29, 2019

Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma. April 29, 2019

Cancer Stem Cell Marker Endoglin (CD105) Induces Epithelial Mesenchymal Transition (EMT) but Not Metastasis in Clear Cell Renal Cell Carcinoma. April 26, 2019

Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth. April 26, 2019

Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia. April 26, 2019

Efficacy and Safety of Nivolumab in Patients with Metastatic Renal Cell Carcinoma and Brain Metastases: Preliminary Results from the GETUG-AFU 26 (Nivoren) Study. April 26, 2019

Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis April 25, 2019

Towards individualized therapy for metastatic renal cell carcinoma. April 25, 2019

The Current State of Adjuvant Therapy Following Surgery for High-risk Renal Cell Carcinoma. April 25, 2019

Do renal cell carcinoma patients with brain metastases still need nephrectomy? April 25, 2019

A Phase 1/2 Study Evaluating the Efficacy and Safety of the Oral CXCR4 Inhibitor X4P-001 in Combination with Axitinib in Patients with Advanced Renal Cell Carcinoma. April 24, 2019

Assessment of concomitant non-oncologic medication in patients with surgically treated renal cell carcinoma: impact on prognosis, cell-cycle progression and proliferation. April 24, 2019

Page 182 of 456